SpringWorks Therapeutics
SWTX
SWTX was delisted on the 30th of June, 2025.
69 hedge funds and large institutions have $895M invested in SpringWorks Therapeutics in 2020 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 23 increasing their positions, 18 reducing their positions, and 4 closing their positions.
300% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 4
28% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 18
21% more funds holding
Funds holding: 57 → 69 (+12)
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
2.49% more ownership
Funds ownership: 74.35% → 76.84% (+2.5%)
27% less capital invested
Capital invested by funds: $1.23B → $895M (-$338M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$18.6M |
| 2 |
Bessemer Group
Woodbridge,
New Jersey
|
+$13.7M |
| 3 |
WP
Woodline Partners
San Francisco,
California
|
+$6.88M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$5.24M |
| 5 |
PA
Perceptive Advisors
New York
|
+$4.79M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$10.2M |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$7.7M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.84M |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$5.17M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$3.07M |
SWTX Hedge Fund Activity: Q1 2020 in Review
69 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in SpringWorks Therapeutics (SWTX) for Q1 2020, worth a combined $895M — down 27% from $1.23B a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new SWTX positions and 4 closed out — a net gain of 12 holders — while 23 added to existing stakes and 18 trimmed.
The largest buyer was Point72 Asset Management, opening a new position worth an estimated $18.6M. The largest seller was BVF Inc, cutting an estimated $10.2M.
- 69 institutional investors held SpringWorks Therapeutics (SWTX) as of Q1 2020, up from 57 in Q4 2019.
- Funds reported $895M of SpringWorks Therapeutics stock for Q1 2020, down 27% quarter-over-quarter.
- 16 funds opened new SpringWorks Therapeutics positions in Q1 2020 and 4 closed out, a net change of +12 holders.
- The largest SpringWorks Therapeutics buyer in Q1 2020 was Point72 Asset Management, an estimated $18.6M added.
- The largest SpringWorks Therapeutics seller in Q1 2020 was BVF Inc, an estimated $10.2M sold.
Based on aggregated 13F filings for Q1 2020.